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SUMMARY – The use of electroretinography (ERG) and optical coherence tomography (OCT) 
has currently expanded beyond ophthalmology alone. The aim of this review is to present the results 
and knowledge acquired by these two methods in patients suffering from schizophrenia. Reviewing 
the studies applying ERG and OCT methods in the field of psychiatry, one can conclude that results 
of the research imply morphological and functional changes of retina in patients with schizophrenia 
that are not consistent. However, in most studies there was reduction of the amplitude and changes in 
the implicit time related parameters on ERG and thinning of the retinal nerve fiber layer on OCT. 
Neurons in the eye use the same neurotransmitters as neurons in the basal brain structures that are 
most affected in schizophrenia, according to the dopamine hypothesis of schizophrenia. Unlike neu-
rons in the basal brain structures, the neurons in the eye are in vivo available to ERG. Using the 
aforementioned tests together with clinical diagnostic criteria of schizophrenia, the subgroups with 
different prognostic and therapeutic specificities within schizophrenia as a group of diseases might be 
identified more precisely.
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Introduction
Schizophrenia is one of the 15 most common dis-
eases that lead to disability and working incapacity1. In 
Croatia, there are more than 18,000 (registered) pa-
tients with schizophrenia, and 1,000 are hospitalized 
on a yearly basis2. Since schizophrenia begins slowly, 
with gradual onset of symptoms, it often remains un-
recognized and untreated for a certain period of time3. 
The period during which the patient manifests symp-
toms of the disease and has not been treated is called 
duration of untreated psychosis (DUP)4. It has been 
proven that the sooner psychopharmacotherapy, psy-
chotherapy and sociotherapy is started, the better is 
prognosis of the disease. Therefore, early detection of 
the disease is of crucial importance for long-term prog-
nosis and favorable outcomes of the disease5. Studies 
have shown that early intervention in healthy individu-
als at a high risk of disease development may reduce the 
incidence of comorbidities such as depressive thoughts, 
suicide attempts, and can generally prolong duration of 
remission of positive and especially negative symp-
toms5,6. Interventions consist of the use of antipsychot-
ics, but also other drugs, as well as various psychothera-
peutic and sociotherapeutic techniques. Although re-
duction in the duration of DUP proved useful, it did 
not reduce the incidence of the disease6.
The disease usually starts between the ages of 18 
and 22, and the occurrence of the disease is equal in 
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both genders1. We still do not have clear pathoana-
tomic, pathophysiologic and etiologic criteria for defi-
nition of the disease. In other words, we are missing a 
clear biologic marker. Therefore, at present, the diag-
nosis of schizophrenia is still made solely based on 
clinical findings and according to the currently used 
diagnostic, symptom-based criteria.
None of the currently available laboratory and 
physical (imaging) tests provides pathognomonic find-
ing for schizophrenia. New studies on electroretinog-
raphy (ERG) and optical coherence tomography 
(OCT) have opened the door to the research of the 
central nervous system in living patients with schizo-
phrenia. Namely, the retina is an integral part of the 
central nervous system and is derived from the same 
tissue as the telencephalon, i.e. the ectoderm. It does 
not contain myelin and is available to visualization and 
investigation in vivo by noninvasive methods. The ax-
ons of the retinal ganglion cells form the optic nerve 
through which the signal is passed to the central ner-
vous system. Thus, there is a premise for investigating 
nervous system in living patients, with the possibility 
of defining specific biologic indicators of schizophre-
nia by noninvasive methods such as ERG and OCT.
The light passes through the cornea and the lens, 
then through the vitreous body to the retina. In the 
retina, it first passes through the ganglion cells, then 
through the layers of the nuclei of the amacrine, bipo-
lar and horizontal cells before reaching a layer of pho-
toreceptors located on the outer part of the retina. 
There are two types of photoreceptors, i.e., rods (for 
black and white viewing and viewing in the dark) and 
cones (for viewing colors and viewing in the light con-
ditions). Photochemical substances are found in the 
outer section of the photoreceptor, which are rhodop-
sin in the rods and different types of photopsin in the 
cones (selective sensitivity for red, blue or green, which 
is the basis of color vision).
From the photoreceptors, the signal is transmitted 
across horizontal and bipolar cells to ganglion cells and 
through the optic nerve, and visual pathways ending in 
the visual cortex located in the occipital lobe. When the 
rods are exposed to light, the resulting receptor potential 
is different from the receptor potentials in almost all 
other sensory receptors. It increases the negativity of 
membrane potential, causing hyperpolarization. Under 
normal conditions when the photoreceptor is not stim-
ulated, the electrical potential is -40 mV, and at maxi-
mum stimuli hyperpolarizes it to -80 mV. The conduc-
tion of most of the signals in the retina neurons occurs 
electrotonically. Electrotonic conduction, unlike an ac-
tion potential, is a direct flow of electrical current in the 
neuron cytoplasm and in the axons from the site of 
stimulation to the synaptic output.
The retina is particularly interesting for investiga-
tions into neurophysiology because many of its cells 
produce neurotransmitters. For example, photorecep-
tors produce glutamate and amacrine cells produce at 
least eight types of neurotransmitters including 
GABA, glycine, dopamine, acetylcholine and indol-
amine. Retinal ganglion cells produce glutamate, so-
matostatin and substance P7. Today, the applicability 
of ERG and OCT has extended beyond its use exclu-
sively in ophthalmology. In vivo biologic indicators as-
sociated with schizophrenia are of great importance in 
studies of the pathogenesis, screening, and early diag-
nosis of disease, as well as the course of disease and 
response to treatment7.
The aim of this review is to present the results and 
knowledge in this area acquired by the application of 
ERG and OCT in schizophrenic patients.
Electroretinography
Electroretinography is a noninvasive diagnostic 
method that measures the outbreaks of electrical po-
tential that arise in response to light in different cells 
within the retina. It is used in ophthalmology to diag-
nose retinal disease (e.g., retinal dystrophies). The sig-
nals that arise are generally of low intensity and are 
measured in nanovolts (nV) or microvolts (mV). There 
are several types of ERG: flash ERG (fERG), full field 
ERG (ffERG), multifocal ERG (mfERG) and pattern 
ERG (pERG).
The electrical potential generated by light stimula-
tion consists of the negative a-wave, which reflects hy-
perpolarization of the photoreceptors, positive b-wave 
that represents depolarization of bipolar and Müller 
cells in the retina, and c-wave as a positive wave that 
arises in response to stimulation of the pigment layer 
and the rods. Photopic negative response (phNR) is 
the negative potential that follows b-wave, and is cre-
ated by ganglion cells. It occurs only in fERG testing. 
ERG records the amplitude of the individual waves, 
the implicit time (time from light stimulation to the 
peak amplitude of waves) and latency (time from the 
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onset of stimulus to the onset of wave). Photopic vi-
sion is vision in bright light conditions, which is neces-
sary for color perception. Cone photoreceptors have 
the main role in recognizing this type of stimulation. 
Scotopic conditions are adaptation of vision in dark-
ness, when rods are activated. Changes in the photore-
ceptor function were recorded in the study by Warner 
et al.8. They analyzed ERG findings in nine patients 
with schizophrenia and nine healthy subjects, and 
showed changes in photoreceptor function in patients 
suffering from schizophrenia. Decreased amplitudes of 
a-waves were identified in patients regardless of the 
dose of antipsychotics. The authors attributed these re-
sults to the absence of omega-3 fatty acids in the cell 
membrane of the retinal photoceptor, which caused 
impaired perception of light, as previously reported 
from the study by Horrobin et al.9. The study was con-
ducted consequently to the research by Marmor et al., 
where difference in electrical potential between pa-
tients with schizophrenia and control group was not 
demonstrated10. The investigation by Warner et al.8 was 
inspired by the observation reported by Gerbaldo et 
al.11 in patients with schizophrenia who had a tenden-
cy of ‘photophilic activity’ (staring at the Sun) and re-
duced sensitivity to light, with lower amplitudes of b-
wave on ERG. Holopigian et al. examined the effect of 
the dopaminergic receptor blocker on the characteris-
tics of fERG. The results showed a decrease in the b-
wave amplitude without changing the implicit time12.
Balogh et al. conducted studies on a sample of 63 
middle aged subjects (26 patients with schizophrenia, 
17 with bipolar affective disorder, and 20 healthy sub-
jects as a control group), aiming to analyze light pro-
cessing in the acute stage of the afore-mentioned dis-
eases using the ERG method13. The findings revealed a 
decrease in the a-wave amplitudes in photopic condi-
tions only in patients in the acute phase of schizophre-
nia, and negative correlation between a-wave ampli-
tudes and positive symptoms (using the Positive and 
Negative Syndrome Scale (PANSS) questionnaire). 
Negative symptoms, as well as the duration of treat-
ment and doses of antipsychotics were not correlated 
with ERG indicators. The abnormality of the wave de-
pended on the stage of the disease because normaliza-
tion of the wave was observed after decrease of symp-
tom intensity. Namely, after eight-week follow up and 
reduction in the intensity of positive symptoms of 
schizophrenia, there were no significant differences 
between patients with schizophrenia and control 
group. ERG abnormalities were not found in the bipo-
lar disorder group.
Hébert et al. found deviation from the normal find-
ings for young, healthy individuals at a high risk of 
developing schizophrenia or bipolar affective disorder 
using ERG14. In their study, population at a high risk 
of developing schizophrenia was defined as having 
positive psychiatric heredity (one parent suffering 
from schizophrenia or bipolar disorder or multi-gen-
eration heredity for these disorders). The study includ-
ed 58 subjects, i.e., 29 subjects with positive heredity 
and 29 healthy controls without any known psychiatric 
heredity. Studies in the scotopic conditions recorded a 
significantly reduced b-wave amplitude in the high-
risk group after correction for age, gender, season at 
the time of testing and heredity, either for schizophre-
nia or bipolar affective disorder14. This research is par-
ticularly important because it suggests that this meth-
od can serve as an early and specific biomarker for the 
risk of developing these mental illnesses and may con-
tribute to the noninvasive, rapid and simple screening, 
early treatment initiation, and more favorable disease 
outcomes14. According to the concept of early inter-
ventions (within a period of up to 5 years from the 
onset of the disease), it is known that when the treat-
ment is started earlier, better long-term outcomes can 
be achieved in terms of remission, recovery, and pa-
tient functionality.
Unlike Balogh et al.13, who found a reduced a-wave 
amplitude in patients with schizophrenia, Hébert et 
al.14 did not prove this. Researchers believe that the 
results varied due to a large sample of subjects with 
bipolar disorder heredity in the study by Hébert et al.14. 
The same researchers later confirmed reduction of a-
wave amplitudes in photopic conditions and reduction 
of b-wave amplitudes in scotopic conditions in adult 
patients with schizophrenia, as indicated in their ear-
lier study on healthy subjects at a high risk of develop-
ing the disease. This was an ERG study with the larg-
est sample to date (105 patients and 150 healthy con-
trols)15.
A group of American researchers used a RETeval 
ERG device (LKC Technologies, Gaithersburg, MD, 
USA) to compare findings in 25 patients with schizo-
phrenia and 25 healthy adult subjects16. Individuals 
with retinal diseases that could affect normal function-
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ing of the retina were not involved in the study. The 
PANSS questionnaire was used to evaluate the sever-
ity of symptoms in patients with schizophrenia in the 
past two weeks.
The advantage of the RETeval ERG device is that 
it does not require dilation of the pupil or direct con-
tact with the cornea. The device uses troland (Td) il-
luminance that measures, adjusts to pupil size, and 
adjusts the intensity of brightness accordingly to en-
sure that a constant number of photoreceptors is stim-
ulated at any time. Subjects were investigated under 
photopic (cone activation) and scotopic (rod activated) 
conditions.
In the first photopic test (P1), a 100 TdˑS repetitive 
flash stimulation of 1 Hz frequency was used without 
background light. In the next photopic test (P2), stim-
ulation with a flash of 100 TdˑS with background of 
340 TdˑS under higher frequency (2 Hz) was used, and 
in the third (PPhNR) test, red light of 58 TdˑS with blue 
background of 380 TdˑS with an even higher frequen-
cy (3.4 Hz) to trigger reaction of ganglion cells was 
used. The last photopic test was the Pf-flicker test that 
uses light flashing of 85 TdˑS at a frequency of 28.3 Hz 
to record the response of bipolar cells (used in psychi-
atric studies for the first time). The scotopic tests con-
sisted of white flashes of 2.8 TdˑS with a frequency 
0.25 Hz for S1 test, 28 TdˑS 0.1 Hz for S2 test and 280 
TdˑS with a frequency of 0.05 Hz for S3 test. All the 
scotopic tests were performed without background 
light.
In the group of patients with schizophrenia, the re-
sults showed that a-wave had a decreased amplitude in 
photopic tests P1 and PPhNR, while b-wave had a de-
creased amplitude in P1 and P2 tests. The a-wave also 
had a decreased amplitude in S3, while a decreased am-
plitude of b-wave was found in S2 and S3 tests. Longer 
latency time of b-wave was observed in P2. In scotopic 
conditions, the implicit time for a-wave and b-wave was 
longer. Pf-flicker test showed a decrease in wave ampli-
tude in the patient group. PPhNR test showed a decrease 
in the wave negativity 72 ms after stimulation.
Correlation of the results on PANSS was signifi-
cant for the following parameters: negative symptoms 
with decreased a-wave amplitudes (photopic PPhNR 
test) and b-wave (scotopic) and with longer implicit 
time of a-wave (scotopic S1 test); negative symptoms 
with reduction of PhNR amplitude 72 ms after stimu-
lus; and excitement symptoms with longer implicit 
time in b-wave (S2). However, after false discovery 
rate corrections, statistically significant remained the 
correlation of negative symptoms with a-wave ampli-
tudes during photopic testing (PPhNR), and correlation 
of excitement symptoms with the implicit time of b-
wave in the scotopic conditions (S2). No correlation 
was demonstrated between the dose of antipsychotic 
pharmacotherapy and retinal response. Researchers 
believe that the correlation of negative symptoms and 
weakened response of the retina (reduced ERG ampli-
tude) to stimulation could indicate the same neu-
rotransmitter pathophysiology based on the neu-
rotransmitter hypothesis of schizophrenia, especially 
the dopaminergic hypothesis16.
The results of these studies examining the charac-
teristics and changes of ERG (a-wave and b-wave am-
plitudes and implicit time) in patients with schizo-
phrenia and the association of reductions in wave am-
plitudes and changes of implicit time in correlation 
with stages of the disease are shown in Table 1. These 
results show a significant role of the ERG method in 
the investigation of pathophysiology of psychiatric 
disorders, especially schizophrenia and bipolar disor-
der. Furthermore, it is a noninvasive method, which is 
well tolerated by adults and children, patients and con-
trol group subjects. Further research should focus on 
better defining these indicators and examining the 
possible mechanisms underlying the ERG changes 
observed.
Optical Coherence Tomography
Optical coherence tomography is a diagnostic meth-
od that uses low coherence light waves to create a high-
resolution cross section image of the retina (1-10 μm). 
The device creates a picture by measuring the echo time 
delay of the light and intensity of the reflected light.
Coherence represents two waves that have a con-
stant phase difference in the stage and the same fre-
quency. A tomogram is a two-dimensional image that 
depicts the intersection of a three-dimensional image; 
by combining multiple tomograms, we get a three-di-
mensional display. The advantage of the OCT is that it 
is a noninvasive and noncontact method that shows 
the real time condition and in vivo. Other advantages 
are that the examination price is relatively low, it is fast, 
and there is no contraindication for the application of 
this diagnostic technique.
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The device first came into use in medicine in the 
early 1990s, and was used primarily in ophthalmology, 
to get an insight into the morphology of the posterior 
segment of the eye, usually for analysis of the morphol-
ogy of the macula and the papilla of the optic nerve. It 
allows measurements of certain structures and possible 
pathologic changes in them, such as glaucoma, diabetic 
maculopathy and retinopathy, age-related macular de-
generation, macular rupture and pseudorupture, central 
serous maculopathy and epiretinal membranes17. Today, 
its usefulness is recognized in other medical specialties, 
e.g., in interventional cardiology as a useful supple-
mentary diagnostic device in percutaneous coronary 
interventions (PCI)18, in dermatology in the diagnosis 
of non-melanoma skin tumors and other inflammatory 
skin diseases19, and in neurology where signs of some 
diseases can be found in the retina (in Alzheimer’s dis-
ease, Parkinson’s disease, multiple sclerosis)20. Thinning 
of the retinal nerve fiber layer (RNFL) has been dem-
onstrated in patients with optic neuritis, multiple scle-
rosis, mild cognitive disorders21, and in patients with 
Alzheimer’s disease22, where it correlates with the se-
verity of cognitive deficits.
Optical coherence tomography imaging in psychi-
atric research including patients suffering from schizo-
phrenia began with Chu et al.23. These authors con-
ducted and published the first study of retinal changes 
using an OCT device in patients with schizophrenia 
and schizoaffective disorder. The study included 49 pa-
tients and 40 healthy controls. Out of 49 patients, 38 
were diagnosed with schizophrenia and 11 with 
schizoaffective disorder. Forty patients had been pre-
scribed antipsychotics, 10 antidepressants, four mood 
stabilizers along with antipsychotics, two only mood 
stabilizers, one had been prescribed hypnotic, and five 
patients were medication free. Control group consisted 
of 40 healthy age- and gender-matched individuals. 
Comparison of retinal thickness indicators between 
the groups was conducted using statistical multilevel 
analyses. Patients with schizoaffective disorder were 
found to have thinner RNFL in the right nasal quad-
rant compared to people with schizophrenia, and the 
severity of positive symptoms was associated with a 
lower macular volume. This study was limited by low 
resolution of the OCT device23.
Samani et al. used Leica Envisu TM SD-OCT 
high resolution device to analyze changes in macula 
and fovea24. They examined 85 participants (35 diag-
nosed with schizophrenia and 50 healthy control sub-
jects). The PANSS questionnaire was used to evaluate 
the severity of symptoms in patients. The macula and 
the fovea (located inside the macula) are particularly 
interesting in research since it is the site of the sharpest 
vision dominated by photoreceptors (cones) and gan-
glion cells.
The device was used to measure thickness of the 
following: RNFL; ganglion cell layer (GCL); inner 
plexiform layer (IPL); inner nuclear layer (INL); outer 
plexiform layer (OPL); outer nuclear layer (ONL); in-
ner segmented layer (ISL); outer segmented layer 
(OSL); cone outer segment tips (COST); and retinal 
pigment epithelium (RPE). The derived measures in-
cluded thickness of the following: whole retina = RN-
FL-RPE; photoreceptor complex = ONL-COST; 
processing/processing complex = RNFL-OPL; and 
ganglionic cell complex = GCL+IPL. Sensitivity to 
contrast was also measured in 44 patients and 44 con-
trols (selected depending on their Freiburg Acuity Test 
results) and showed spherical equivalent to be lower in 
patients. The results showed significant reduction in 
thickness of the photoreceptor complex in all regions, 
thinning of the OPL and ISL in patients with schizo-
phrenia. In addition, reduction of contrast sensitivity 
was correlated with thinning of the temporal parafo-
veal ganglion cell complex. The severity of negative 
symptoms was negatively correlated with thickness of 
the foveal photoreceptor complex and ONL.
Ascaso et al. examined 30 patients with schizo-
phrenia and 30 healthy controls25. The subjects were 
examined by Time Domain OCT (TD-OCT) to es-
tablish differences between the groups regarding the 
existence of a recent psychotic episode in the last 
month (recent illness episode, RIE) or the last six 
months (non-recent illness episode, NRIE) in relation 
to control. The incidence and intensity of symptoms 
were evaluated by the PANSS questionnaire. All pa-
tients were treated with antipsychotics. Since this de-
vice does not adjust to the pupil size, the pupils were 
dilated with 1% tropicamide. Thickness of the RNFL, 
thickness of the macula and macular volume were 
measured. All patients were found to have thinning of 
the peripapillary RNFL in all quadrants of both eyes. 
Macular thickness and macula volume were also re-
duced in all patients in both eyes. Thickness of the 
macular inner ring, foveal thickness, and the volume of 
macula of the left eye were statistically significantly re-
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duced. Comparison of the two patient subgroups (RIE 
and NRIE) yielded significant differences in the 
above-mentioned characteristics compared to the con-
trol group, which were mainly identified in NRIE pa-
tients. The authors claim that inflammation could be 
the reason why a significant difference was not found 
in the RIE subgroup, i.e., inflammatory processes in-
crease thickness of the human retina, as previously 
shown by Stock et al.26. Inflammatory processes have 
been described in patients with schizophrenia, during 
acute episodes of schizophrenia, both in the first psy-
chosis episode and in chronic patients27,28. With the 
use of multivariate regression models and after correc-
tion for age, no significant link was found in this study 
between duration of the disease and thickness of the 
peripapillary RNFL, macular thickness and macular 
density either in all subjects or in patient subgroups26.
Scientists from Kuala Lumpur examined the use of 
SD-OCT to analyze RNFL changes in patients with 
schizophrenia and their association with the duration 
of the disease29. The intensity of symptoms was as-
sessed following the DSM-IV diagnostic criteria and 
using the PANSS questionnaire. Patients (N=30) with 
schizophrenia were divided into subgroups of acute, 
chronic and long-term chronic patients, and compared 
to 30 healthy age-, gender- and race-matched subjects. 
OCT was used to measure thickness of the peripapil-
lary RNFL, average thickness of the macula, and vol-
ume of the macula. Since there were no differences 
between the left and right eye, further research was 
continued solely examining the right eye of the sub-
jects. Differences were found in RNFL thickness be-
tween patients and healthy subjects. In patients with 
schizophrenia, significant differences in RNFL thick-
ness were found in the peripapillary area of the retina 
in the superior, inferior and temporal quadrant, but 
not in the nasal quadrant. Significantly thinner macula 
in general, as well as thinning of the central part of the 
macula, inner and outer ring of the macula in patients 
compared to controls was also identified. When the 
inner and outer rings were divided into quadrants, a 
significant difference between the groups was demon-
strated in all quadrants. The volume of the macula was 
also reduced in patients. The RNFL size and reduction 
in the volume of the macula were more significant in 
long-term chronic patients and were significantly re-
lated to the duration of the disease. Such results indi-
cate the value of the OCT method applied in moni-
toring of disease progression. However, correlation of 
the obtained parameters with rating of the PANSS 
questionnaire was not demonstrated. The authors at-
tributed these results to the neurodegenerative nature 
of the disease and to neurochemical dysregulation27. It 
has been demonstrated that the dopamine neurotrans-
mitter system plays a major role in visual functions 
such as contrast sensitivity and color perception30. 
Contrast sensitivity and color perception are affected 
in diseases with dopaminergic issues such as Parkin-
son’s disease, but also in schizophrenia31. Therefore, 
thinning of the RNFL has been attributed to the pos-
sible dopamine dysregulation24,25.
Using the same method, Yilmaz et al.32 found sta-
tistically significant thinning of the RNFL also in the 
nasal quadrant in patients compared to healthy sub-
jects. They analyzed the findings using SD-OCT in 34 
patients with schizophrenia and 30 healthy individuals 
to determine changes in RNFL thickness. Thickness 
of the macula in the nasal quadrant and the inferior 
outer quadrant was also significantly thinner in pa-
tients. The average macular thickness and thickness of 
the macula in superior external, superior internal, tem-
poral external and temporal internal, nasal internal and 
inferior interior quadrants were all reduced, but not 
significantly. The researchers attributed these changes 
to the neurodegenerative nature of schizophrenia.
Silverstein et al.33 examined the influence of co-
morbidities in patients with schizophrenia on the re-
sults obtained using SD-OCT. Compared to the group 
of healthy subjects, there were no differences in RNFL 
thickness, macula and inner nuclear layer, and the de-
termined thinning of the retinal structures was associ-
ated with diseases such as diabetes mellitus and arte-
rial hypertension in both groups of subjects. The study 
showed changes in the optic nerve head in patients 
with schizophrenia. The study also found an increase 
in cup-to-disc ratio of the optic nerve papilla, which 
was independent of comorbidities. Such results indi-
cate the need for further research of the optic nerve 
head changes as a possible biomarker of schizophrenia.
Joe et al.34 also investigated the use of SD-OCT in 
pursuit of biomarkers in psychosis. They studied macu-
lar thickness and were among the first who studied 
thickness of the vascular layer supplying the retina, i.e., 
choroid. Six chronic psychiatric patients were involved 
(three with schizophrenia and three with bipolar dis-
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trols. As in previous studies, they found thinning of 
the macula, especially the inner ring of the macula 
(statistically significant), which they attributed to neu-
rodegenerative changes. They also found thinning of 
the choroid in the individuals with psychosis, but it 
was not statistically significant, which they attributed 
to a small sample of study participants. The authors 
indicate the need for further research of these changes 
and their association with inflammation and degener-
ative changes of the central nervous system.
From the above, we can conclude that the majority 
of studies using the OCT in patients with schizophre-
nia determined thinning of the RNFL (Table 2). These 
results are undermined by methodologic limitations of 
the studies, such as relatively small samples and co-
morbidities (e.g., diabetes and arterial hypertension) 
with possible influences on the retinal structures ex-
amined.
Conclusion
Reviewing the research regarding the application 
of ERG and OCT methods in the field of psychiatry, 
one can conclude that the results of research conduct-
ed imply morphological and functional changes in pa-
tients with schizophrenia that are not consistent. 
However, in most studies, there was reduction in the 
amplitude and changes in the implicit time related pa-
rameters in the ERG, and thinning of the RNFL in 
the OCT. Further, especially longitudinal prospective 
research is needed to define specific biologic indicators 
using these methods for the purpose of early screening, 
diagnostics and monitoring of patients in certain stag-
es of the disease, and for therapeutic response in pa-
tients. There is an obvious need for longitudinal pro-
spective research in order to define specific biologic 
indicators using these methods for the possible early 
screening, differential diagnosis, monitoring of relapse 
and therapeutic response of patients in specific stages 
of the disease. The neurons in the eye are available in 
vivo, and they use the same neurotransmitters as the 
neurons in the basal brain structures that are most af-
fected in schizophrenia according to the dopamine 
hypothesis of schizophrenia. The use of ERG and 
OCT, along with the established clinical diagnosis of 
schizophrenia can help define clear subgroups within 
schizophrenia as a group of diseases according to ERG 
and OCT findings. These subgroups would have dif-
ferent prognostic and therapeutic specificities35,36. We 
can also expect a clear and defined biologic marker 
that would increase the accuracy of the disease diagno-
sis and enable early initiation of treatment.
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Sažetak
PRIMJENA ELEKTRORETINOGRAFIJE I OPTIČKE KOHERENTNE TOMOGRAFIJE  
U BOLESNIKA SA SHIZOFRENIJOM
D. Duraković, A. Silić, V. Peitl, R. Tadić, K. Lončarić, T. Glavina, D. Šago, Lj. Pačić Turk i D. Karlović
Primjena elektroretinografije (ERG) i optičke koherentne tomografije (OCT) danas nadilazi primjenu isključivo u oftal-
mologiji. Cilj ovoga pregleda je prikazati rezultate i spoznaje dobivene primjenom ovih metoda u shizofrenih bolesnika. 
Pregledom dosadašnjih istraživanja primjene metoda ERG-a i OCT-a u području psihijatrije možemo zaključiti da rezulta-
ti provedenih istraživanja morfoloških i funkcionalnih promjena retine u bolesnika sa shizofrenijom nisu konzistentni. Ipak, 
u većini istraživanja nalaze se smanjenje amplituda i promjene implicitnog vremena u ERG-u te stanjenje sloja mrežničnih 
živčanih vlakana na OCT-u. Kako se radi o neuronima dostupnima in vivo koji koriste iste neurotransmitere kao i neuroni 
u središnjim strukturama mozga koji su po dopaminskoj hipotezi shizofrenije najzahvaćeniji, primjenom spomenutih pretra-
ga uz uobičajenu dijagnostiku shizofrenije možemo očekivati definiranje jasnijih podskupina unutar shizofrenije kao skupine 
bolesti koje bi imale različite prognostičke i terapijske specifičnosti.
Ključne riječi: Shizofrenija; Elektroretinografija; Optička koherentna tomografija; Neurooftalmologija
